Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 can cause skin problems.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

SIM01 significantly reduced post-COVID symptoms and is safe.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Possible link between COVID-19 and hair loss; more research needed.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

More research is needed to understand sex and racial differences in long COVID.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.